Nachrichten zur AbCellera Biologics Inc Aktie

Investors were surely discovering drug discovery company AbCellera Biologics (NASDAQ: ABCL) as the trading week kicked off on Monday. On…

AbCellera Biologics (ABCL) delivered earnings and revenue surprises of 11.76% and 49.82%, respectively, for the quarter ended March 2025. Do…

…

ABCL earnings call for the period ending December 31, 2024.…

AbCellera Biologics (ABCL) delivered earnings and revenue surprises of 26.67% and 40.83%, respectively, for the quarter ended December 2024. Do…

Abcellera Biologics, other AI health stocks gain as Ellison touts AIs promise…

…

Theres no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...…

ABCL earnings call for the period ending September 30, 2024.…

…

ABCL earnings call for the period ending June 30, 2024.…

Wall Street analysts say this drug developer can more than double your money.…

Wall Street analysts say this drug developer can more than double your money.…

ABCL earnings call for the period ending March 31, 2024.…

…